Crinetics Pharmaceuticals CRNX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $18.07M+135% | $7.7M+401% | $1.54M+10.3% | $1.39M+83.2% | $760K-26.9% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $1.14M+9.7% | ||
| $355.9M+7.2% | $332.06M+5.9% | $313.57M+10.0% | $285.01M+8.3% | $263.06M+9.5% | ||
| —— | $191.33M+13.6% | $168.43M+15.7% | $145.53M+18.7% | $122.64M+23.0% | ||
| —— | —— | $165.81M+18.9% | $139.44M+21.8% | $114.44M+14.7% | ||
| —— | —— | —— | —— | $366.69M+7.9% | ||
| -$545.74M-5.6% | -$516.77M-8.1% | -$477.85M-13.0% | -$423.06M-12.3% | -$376.73M-11.2% | ||
| -3,020.3%+3,694pp | -6,714.8%+24,415pp | -31,130.2%-738pp | -30,392.2%+19,178pp | -49,569.7%-16,956pp | ||
| $49.53M-4.1% | $51.63M-5.7% | $54.75M+2.9% | $53.23M+9.8% | $48.48M+18.5% | ||
| —— | $180K+33.3% | $135K+50.0% | $90K+100% | $45K— | ||
| -$496.39M-6.7% | -$465.32M-10.0% | -$423.1M-14.4% | -$369.83M-12.7% | -$328.25M-10.0% | ||
| -2,747.2%+3,299pp | -6,046.2%+21,517pp | -27,563.3%-995pp | -26,568.5%+16,623pp | -43,191.1%-14,470pp | ||
| -$5.13-3.8% | -$4.94-9.3% | -$4.52-10.2% | -$4.10-7.6% | -$3.81-3.0% | ||
| -$541.62M-5.6% | -$512.88M-8.2% | -$474.16M-13.0% | -$419.62M-12.3% | -$373.49M-11.1% | ||
| -2,997.5%+3,667pp | -6,664.2%+24,226pp | -30,890.2%-745pp | -30,144.9%+18,999pp | -49,143.9%-16,799pp | ||
| -$545.74M-5.6% | -$516.77M-8.1% | -$477.85M-13.0% | -$423.06M-12.3% | -$376.73M-11.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Crinetics Pharmaceuticals's profit margins?
- Gross margin is 150.0% and operating margin is -3020.3%, with a -2747.2% net margin.
- Where does Crinetics Pharmaceuticals's income statement data come from?
- Every line is extracted from Crinetics Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.